Halozyme Therapeutics Statistics
Total Valuation
HALO has a market cap or net worth of $7.45 billion. The enterprise value is $8.28 billion.
| Market Cap | 7.45B |
| Enterprise Value | 8.28B |
Important Dates
The last earnings date was Monday, November 3, 2025, after market close.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HALO has 117.60 million shares outstanding. The number of shares has decreased by -3.31% in one year.
| Current Share Class | 117.60M |
| Shares Outstanding | 117.60M |
| Shares Change (YoY) | -3.31% |
| Shares Change (QoQ) | -1.47% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 103.89% |
| Float | 116.22M |
Valuation Ratios
The trailing PE ratio is 13.37 and the forward PE ratio is 8.51.
| PE Ratio | 13.37 |
| Forward PE | 8.51 |
| PS Ratio | 6.22 |
| Forward PS | 4.55 |
| PB Ratio | 14.77 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.36 |
| P/OCF Ratio | 12.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.19, with an EV/FCF ratio of 13.75.
| EV / Earnings | 13.91 |
| EV / Sales | 6.67 |
| EV / EBITDA | 10.19 |
| EV / EBIT | 11.23 |
| EV / FCF | 13.75 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 3.05.
| Current Ratio | 1.59 |
| Quick Ratio | 1.25 |
| Debt / Equity | 3.05 |
| Debt / EBITDA | 1.87 |
| Debt / FCF | 2.55 |
| Interest Coverage | 41.53 |
Financial Efficiency
Return on equity (ROE) is 124.50% and return on invested capital (ROIC) is 22.87%.
| Return on Equity (ROE) | 124.50% |
| Return on Assets (ROA) | 21.24% |
| Return on Invested Capital (ROIC) | 22.87% |
| Return on Capital Employed (ROCE) | 53.28% |
| Revenue Per Employee | $3.55M |
| Profits Per Employee | $1.70M |
| Employee Count | 350 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, HALO has paid $150.45 million in taxes.
| Income Tax | 150.45M |
| Effective Tax Rate | 20.17% |
Stock Price Statistics
The stock price has increased by +30.28% in the last 52 weeks. The beta is 0.95, so HALO's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +30.28% |
| 50-Day Moving Average | 68.20 |
| 200-Day Moving Average | 63.13 |
| Relative Strength Index (RSI) | 33.79 |
| Average Volume (20 Days) | 2,707,467 |
Short Selling Information
The latest short interest is 12.48 million, so 10.61% of the outstanding shares have been sold short.
| Short Interest | 12.48M |
| Short Previous Month | 11.31M |
| Short % of Shares Out | 10.61% |
| Short % of Float | 10.74% |
| Short Ratio (days to cover) | 5.47 |
Income Statement
In the last 12 months, HALO had revenue of $1.24 billion and earned $595.49 million in profits. Earnings per share was $4.74.
| Revenue | 1.24B |
| Gross Profit | 980.76M |
| Operating Income | 737.40M |
| Pretax Income | 745.94M |
| Net Income | 595.49M |
| EBITDA | 813.28M |
| EBIT | 737.40M |
| Earnings Per Share (EPS) | $4.74 |
Balance Sheet
The company has $701.96 million in cash and $1.54 billion in debt, giving a net cash position of -$836.90 million or -$7.12 per share.
| Cash & Cash Equivalents | 701.96M |
| Total Debt | 1.54B |
| Net Cash | -836.90M |
| Net Cash Per Share | -$7.12 |
| Equity (Book Value) | 503.92M |
| Book Value Per Share | 4.29 |
| Working Capital | 491.52M |
Cash Flow
In the last 12 months, operating cash flow was $611.00 million and capital expenditures -$8.60 million, giving a free cash flow of $602.40 million.
| Operating Cash Flow | 611.00M |
| Capital Expenditures | -8.60M |
| Free Cash Flow | 602.40M |
| FCF Per Share | $5.12 |
Margins
Gross margin is 78.91%, with operating and profit margins of 59.33% and 47.91%.
| Gross Margin | 78.91% |
| Operating Margin | 59.33% |
| Pretax Margin | 60.02% |
| Profit Margin | 47.91% |
| EBITDA Margin | 65.44% |
| EBIT Margin | 59.33% |
| FCF Margin | 48.47% |
Dividends & Yields
HALO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.31% |
| Shareholder Yield | 3.31% |
| Earnings Yield | 8.00% |
| FCF Yield | 8.09% |
Analyst Forecast
The average price target for HALO is $73.33, which is 15.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $73.33 |
| Price Target Difference | 15.79% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 9.45% |
| EPS Growth Forecast (5Y) | 16.41% |
Stock Splits
The last stock split was on December 10, 2003. It was a forward split with a ratio of 4.275:1.
| Last Split Date | Dec 10, 2003 |
| Split Type | Forward |
| Split Ratio | 4.275:1 |
Scores
HALO has an Altman Z-Score of 4.74 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.74 |
| Piotroski F-Score | 7 |